Trial Profile
Clinical outcome of metformin in patients with advanced hepatocellular carcinoma receiving sorafenib.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Aug 2015 New trial record